SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SARomics Biostructures AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10861
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein NMR spectroscopy and structure-based drug design. It offers protein and peptide optimization service which helps to predict the effect of a single amino acid replacement from data containing complex substitution patterns. Saromics also provides integrated drug discovery services including fragment screening based on chromatography ligand screening technology. The organization has operations in the US and Sweden. Saromics is headquartered in Lund, Sweden.

SARomics Biostructures AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
SARomics Biostructures Enters into Distribution Agreement with Carna Biosciences 10
SARomics Biostructures Enters into Research Agreement with inSili.com 11
SARomics Enters Into Drug Discovery Agreement With Red Glead For FBLD Platform 12
SARomics Biostructures AB – Key Competitors 13
SARomics Biostructures AB – Key Employees 14
SARomics Biostructures AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Key Facts 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Deals By Therapy Area, 2012 to YTD 2018 8
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SARomics Biostructures Enters into Distribution Agreement with Carna Biosciences 10
SARomics Biostructures Enters into Research Agreement with inSili.com 11
SARomics Enters Into Drug Discovery Agreement With Red Glead For FBLD Platform 12
SARomics Biostructures AB, Key Competitors 13
SARomics Biostructures AB, Key Employees 14
SARomics Biostructures AB, Other Locations 15
SARomics Biostructures AB, Joint Venture 15

List of Figures
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cyanotech Corp:企業の戦略・SWOT・財務分析
    SummaryCyanotech Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Corpak MedSystems, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Corpak MedSystems, Inc. (Corpak) is a medical device company. The company manufactures and markets medical devices for the enteral feeding and bedside location technology markets. Its products include CORTRAK 2 enteral access system, CORFLO enteral feeding tubes, and THE FARRELL valve system …
  • Titan Company Limited (TITAN):企業の財務及び戦略的SWOT分析
    Summary Titan Company Limited (Titan) is a watch manufacturing company that manufactures watches with quartz technology. The company operates in four business divisions namely; watches and accessories; jewellery; eyewear and precision engineering. Its jewellery division products include earring, pen …
  • Hologic Inc (HOLX):企業のM&A・提携動向(医療分野)
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • Uchida Esco Co., Ltd. (4699):企業概要、財務及び戦略的SWOT分析
    Summary Uchida Esco Co., Ltd. (Uchida) is a software development company. The company provides hardware maintenance and office services. It focuses on sale and maintenance service for information processing equipment, communications equipment, peripherals, and related products; development, sales, m …
  • Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Petroleo Brasileiro SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • VT Systems, Inc.:企業の戦略・SWOT・財務分析
    SummaryVT Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • 3MV Energy Corp:企業のM&A・提携動向(石油・ガス分野)
    Summary 3MV Energy Corp (3MV Energy), formerly Noravena Capital Corp is an oil and gas company that explores, develops, produces and acquires petroleum and natural gas properties in Western Canada. The company operates in Saskatchewan region with production facilities in the Dodsland and Fiske commu …
  • Electrica S.A. (EL):企業財務及び戦略的SWOT分析
    Summary Electrica S.A. (Electrica) is an electric utility that operates distribution networks, and supplies power. The company distributes electricity through its subsidiaries Electrica Distributie Muntenia Nord, Electrica Distributie Transilvania Nord, and Electrica Distributie Transilvania Sud. Th …
  • Vertu Motors Plc:企業のM&A・提携・投資分析
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Aurora Health Care Inc:企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oriental Carbon and Chemicals Limited (506579):企業の財務及び戦略的SWOT分析
    Summary Oriental Carbon and Chemicals Limited (OCCL) is a chemical company that manufactures and markets insoluble sulphur. The company’s products include diamond sulf and sulfuric acid. Its diamond sulf is an amorphous form of sulfur in polymeric form in contrast to the natural sulfur which is crys …
  • Gerdau S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gerdau S.A. Mergers and Acquisi …
  • Amana Cooperative Insurance Company (8310):企業の財務及び戦略的SWOT分析
    Summary Amana Cooperative Insurance Company (AMANA) is a financial service provider that provides insurance and personal deposit solutions for individual and corporate industries. The company offers insurance products such as property, car, fire, marine and land shipments, engineering, health and ot …
  • Big Rivers Electric Corporation:企業の発電所・SWOT分析2018
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Incyte Corporation (INCY):企業の財務及び戦略的SWOT分析
    Incyte Corporation (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ORIX Corporation:企業のM&A・提携・投資分析
    ORIX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORIX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Capricor Therapeutics Inc (CAPR):企業財務及び戦略的SWOT分析
    Summary Capricor Therapeutics Inc (Capricor) discovers, develops and commercializes therapeutics for various diseases. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced heart failure and duchenne muscular dystrophy associated c …
  • Portola Pharmaceuticals, Inc.:企業のM&A・提携・投資分析
    Portola Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Portola Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆